Article
Northridge, CA-Researchers with multidisciplinary expertise are collaborating to develop a miniature, implantable sensor that could continuously monitor IOP, said Leon G. Partamian, MD.
Bausch + Lomb voluntarily recalls select enVista IOLs
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Electroretinography reveals limited duration of dexamethasone implant efficacy in DME
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Beyond mentoring: The power of sponsorship and advocacy in ophthalmology
Nanoscope Therapeutics publishes clinical data on vision restoration in retinitis pigmentosa